Why Biotech Firms Like Buckeye Land

From Amgen to Sarepta, biomedical companies bet big on the Columbus Region.

By Ron Starner / July 8, 2022

Sarepta1

How do you measure the impact of bioscience innovation in a market? Is it done through metrics like federal research grants and patents filed? Is it done by counting industry expansion projects, capital investment totals and jobs created? Or is it measured in other ways?

Perhaps it’s done best by counting the number of lives saved and measuring the improvement in quality of life among patients battling chronic disease.

Whichever metric you choose, there’s no debating that one of the most impactful bioscience markets in the world today resides in the Columbus Region of Central Ohio.

Read full article here.

Related content

  • Why Amgen Chose the Columbus Region and Why It Matters

    August 9, 2022

    Why Amgen Chose the Columbus Region and Why It Matters

    Rendering of Amgen’s new facility. In a string of economic development wins for the Columbus Region, one stands…

    Read More

  • Why Biotech Firms Like Buckeye Land

    July 8, 2022

    Why Biotech Firms Like Buckeye Land

    How do you measure the impact of bioscience innovation in a market? Is it done through metrics like…

    Read More

  • It’s in our DNA: Why the Columbus Region is a Hub for Gene Therapy Companies

    May 23, 2022

    It’s in our DNA: Why the Columbus Region is a Hub for Gene Therapy Companies

    When Amgen selected the Columbus Region for its newest and most advanced biomanufacturing plant in 2021, you could…

    Read More